The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,062.00
Bid: 12,018.00
Ask: 12,022.00
Change: 38.00 (0.32%)
Spread: 4.00 (0.033%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares reach record high, oil tops $60 a barrel

Mon, 08th Feb 2021 13:05

* MSCI all-country world share index at record high

* European indexes climb early on, U.S. futures gain

* Oil crosses $60 a barrel

* Hopes of $1.9 trln U.S. stimulus, vaccines boosting
sentiment

* U.S. dollar retreats from recent highs

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2021 http://tmsnrt.rs/2egbfVh

*

By Marc Jones

LONDON, Feb 8 (Reuters) - World shares set another record
high on Monday and oil surpassed $60 a barrel for the first time
in a year, on hopes that a $1.9 trillion COVID-19 aid package
will be passed by U.S. lawmakers as soon as this month.

Even news that South Africa had halted the rollout of
AstraZeneca's vaccine after a study showed it gave only limited
protection against the country's more contagious variant of the
virus wasn't going to put equity markets off.

MSCI's 50-country index of world stocks hit
its ninth record high of 2021 overnight as Tokyo's Nikkei
jumped on talk of Japan's relaxing emergency
restrictions and as China's markets got busy before the
start of the lunar new year.

Europe then made a strong start to the week as higher oil
prices and inflation expectations lifted basic resource
and banking shares 2% and 1.5%, and France's Veolia
launched a hostile 11.3 billion-euro takeover bid for waste and
water rival Suez.

"A generalised risk-on tone is pushing stocks higher,"
UniCredit's analysts said in a note.

Bond markets were moving, too, as focus intensified on how
far inflation might rise if the current mix of stimulus, rising
oil and food prices and expectations for a reopening economies
continue to hold.

Ten-year U.S. Treasury yields, which are one of the main
drivers of global borrowing costs, climbed above 1.2% for the
first time since the peak of coronavirus uncertainty last March.

Break-even rates, which account for inflation, traded as
high as 2.21%, their highest since 2014 while in Europe,
Germany's 10-year yields were near five-month highs at -0.42%
, near .

"It will be hard not to see inflation in something when we
get what is likely to be a short-term stimulus boost," Deutsche
Bank's Jim Reid said, referring to planned U.S. stimulus.

"Whether that will be in goods, wages or asset prices or all
three remains to be seen, but it seems inevitable there will be
an impact."

That renewed focus on inflation came as Brent crude
touched an intraday high of $60.06 a barrel, the highest since
January last year.

Saudi Arabia's pledge of extra output cuts in February and
March on the back of reductions by other OPEC members its
allies, including Russia, is helping to limit supply and support
prices.

In a further sign of that supply dynamic, the six-month
Brent spread <LCOc1-LCOc7> hit its highest in more than year,
$2.45. OCBC's economist Howie Lee said the Saudis had sent
another "very bullish signal" last week too by keeping its Asian
prices unchanged.

"I don't think anybody dares to short the market when Saudi
is like this," he said.

STIMULUS

Asia's overnight rally had seen Japan's Nikkei close
up 2%, Chinese blue-chip shares advance 1.5% and
Australian shares finish 0.6% higher.

Wall Street futures were pointing 0.3% higher after the
Nasdaq and S&P 500 both climbed to record highs on Friday as
weak monthly U.S. jobs data supported expectations
of stimulus and after some strong corporate earning.

U.S. President Joe Biden and his Democratic allies in
Congress forged ahead with their stimulus plan on Friday as
lawmakers approved a budget outline that will allow them to
muscle through in the coming weeks without Republican support.

U.S. Treasury Secretary Janet Yallen predicted the United
States would reach full employment next year if Congress can
pass its support package.

"That's a big call, given full employment is 4.1%, but one
that will sit well with the market at a time when the
vaccination program is being rolled out efficiently in a number
of countries," said Chris Weston, Melbourne-based chief
strategist at Pepperstone.

Expectations of a U.S. economic recovery have not boosted
the dollar, however, "although much of the optimism towards U.S.
macro is probably well founded," said Kristoffer Kjær Lomholt,
chief analyst, FX and rates strategy at Danske Bank.

"The U.S. jobs recovery has more or less stalled (though),
and that did leave some space to take EUR/USD higher. The next
big theme that may be priced further in to spot is moving ahead
with U.S. fiscal talks."

Indeed, the dollar came off a four-month high against the
Japanese yen to be last at 105.50. The euro was
weaker again though at $1.2022 after rising 0.7% on Friday to a
one-week high.

Data showed German industry avoided a contraction in
December. Despite coronavirus lockdowns at home and abroad,
demand from China helped export-oriented manufacturers in
Europe's largest economy weather the COVID-19 pandemic.

The risk-sensitive Australian dollar eased from a
one-week high to $0.7655 while South Africa's rand fell
nearly 0.5% after its AstraZeneca vaccine troubles.

(Additional reporting by Swati Pandey in Sydney, editing by
Larry King)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.